Aptus Pharma Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
372.00 -6.95 (-1.83%)Updated : 20 Apr 2026
Fiscal Period202520242023
Period End DateMar 25Mar 24Mar 23
Total Operating Expense 19.9816.5313.46
Other Net -0.17-0.08-0.04
Diluted Weighted Average Shares 0.690.690.69
Depreciation/ Amortization 0.270.210.18
Operating Income 4.581.330.44
Net Income 3.100.800.19
Income Availableto Com Excl Extra Ord 3.100.800.19
Net Income Before Taxes 4.201.120.30
Other Operating Expenses Total 4.324.765.13
Net Income After Taxes 3.100.800.19
Income Availableto Com Incl Extra Ord 3.100.800.19
Costof Revenue Total 9.046.834.76
Gross Profit 15.5211.039.13
Interest Inc( Exp) Net- Non- Op Total -0.22-0.14-0.10
Diluted Net Income 3.100.800.19
Provisionfor Income Taxes 1.100.320.10
period Type ---
Net Income Before Extra Items 3.100.800.19
Total Revenue 24.5617.8613.90
period Length 12.0012.0012.00
Revenue 24.5617.8613.90
Selling/ General/ Admin Expenses Total 6.354.723.39
Diluted Normalized EPS 4.521.160.28
Diluted EPS Excluding Extra Ord Items 4.521.160.28
*All figures in crores except per share values
Recommended For You
Trending Stocks
245.05+8.85(3.75%)
4,077.55+123.65(3.13%)
1,340.70-9.85 (-0.73%)
1,868.00-2.40 (-0.13%)